Beta Bionics, Inc. Common Stock (BBNX) Stock Price

BBNXStock

$16.35−20.75%52W

Market Cap$882.02M

P/E—

PEG Ratio—

Div yield—

Beta0.78

BBNX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)28.54%

Price vs S&P 500 (4W)-24.49%

VGM Score57.74

Book Value / Share (Quarterly)$5.70

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)724.29%

Cash Flow / Share (Quarterly)$-1.37

Price vs S&P 500 (YTD)-58.27%

Gross Margin (TTM)58.31%

Net Profit Margin (TTM)-61.32%

EPS (TTM)$-1.65

10-Day Avg Trading Volume0.94M

EPS Excl Extra (TTM)$-1.65

EPS (Annual)$-1.81

ROI (Annual)-25.45%

Gross Margin (Annual)55.40%

Cash / Share (Quarterly)$4.01

Revenue Growth QoQ (YoY)37.76%

ROA (Last FY)-22.27%

Revenue Growth TTM (YoY)94.09%

EBITD / Share (TTM)$-1.83

Operating Margin (TTM)-69.75%

Cash Flow / Share (Annual)$-1.27

P/B Ratio3.44x

P/B Ratio (Quarterly)2.72x

Net Income / Employee (Annual)$-174,300

EV / Revenue (TTM)7.04x

ROA (TTM)-23.25%

EPS Incl Extra (Annual)$-1.81

Current Ratio (Annual)8.66x

Quick Ratio (Quarterly)7.72x

3-Month Avg Trading Volume1.22M

52-Week Price Return-20.75%

Revenue / Employee (TTM)$283,400

P/S Ratio (Annual)8.80x

Asset Turnover (Annual)0.30x

52-Week High$32.71

EPS Excl Extra (Annual)$-1.81

26-Week Price Return38.44%

Quick Ratio (Annual)7.73x

13-Week Price Return-5.44%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.88x

Enterprise Value$837.70M

Asset Turnover (TTM)0.38x

Revenue / Employee (Annual)$238,700

Inventory Turnover (Annual)2.55x

Pretax Margin (Annual)-73.02%

Cash / Share (Annual)$4.94

3-Month Return Std Dev77.79%

Net Income / Employee (TTM)$-173,700

ROE (Last FY)-25.45%

EPS Basic Excl Extra (Annual)$-1.81

Receivables Turnover (TTM)7.59x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.65

Receivables Turnover (Annual)6.34x

ROI (TTM)-26.30%

P/S Ratio (TTM)7.41x

Revenue / Share (Annual)$2.47

Price vs S&P 500 (52W)-36.28%

Year-to-Date Return-46.34%

5-Day Price Return-8.45%

EPS Normalized (Annual)$-1.81

Net Profit Margin (Annual)-73.02%

Month-to-Date Return-13.86%

EBITD / Share (Annual)$-1.73

Operating Margin (Annual)-71.50%

EPS Basic Excl Extra (TTM)$-1.65

P/B Ratio (Annual)4.66x

Inventory Turnover (TTM)2.41x

Pretax Margin (TTM)-61.32%

Book Value / Share (Annual)$6.48

Price vs S&P 500 (13W)-8.12%

Beta0.78x

Revenue / Share (TTM)$2.67

ROE (TTM)-26.30%

52-Week Low$8.80

vGradeD

gGradeA

mGradeC

vgmGradeC

BBNX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 29, 2026	-$0.56	-$0.36	+35.09%(+$0.20)
Q1 2026	Apr 21, 2026	-$0.45	-$0.36	+21.06%(+$0.10)
Q4 2025	Feb 17, 2026	-$0.38	-$0.19	+49.38%(+$0.19)
Q3 2025	Oct 28, 2025	-$0.41	-$0.33	+19.84%(+$0.08)
Q2 2025	Jul 29, 2025	-$0.47	-$0.27	+41.43%(+$0.19)

BBNX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

4.12

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Beta Bionics, Inc. Common Stock

Beta Bionics is a commercial-stage medical device company developing the iLet Bionic Pancreas, an automated insulin delivery system using adaptive closed-loop algorithms for people with insulin-dependent diabetes. The company's proprietary technology is designed to simplify diabetes management and improve patient outcomes by automating insulin dosing. Beta Bionics operates a focused business model centered on the development, manufacturing, and commercialization of the iLet platform.

BBNX Next Earnings Report

Report dateOct 27, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.51

Revenue estimate$34.59M

Also reporting on Oct 27, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for October 2026

BBNX Insider Transactions

SellOct 1, 2026
HOPMAN MARK
Officer
Shares: 370Value: $7,015
SellSep 22, 2026
JONES CHRISTY
Director
Shares: 6,430Value: $147,890
SellSep 16, 2026
HOPMAN MARK
Officer
Shares: 30,779Value: $619,640
SellSep 16, 2026
MENSINGER MIKE
Officer
Shares: 2,650Value: $58,300
SellSep 14, 2026
HOPMAN MARK
Officer
Shares: 775Value: $12,028

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for October 2026

Companies in Related Industries

ENOVEnovis CorporationOrthopedic & Prosthetic Devices
CDRECadre Holdings, Inc.Orthopedic & Prosthetic Devices
STAAStaar Surgical CoOphthalmic Goods
CBLLCeriBell, Inc. Common StockElectromedical Equipment
KODKEASTMAN KODAK COMPANYPhotographic Equipment & Supplies
INMDInMode Ltd. Ordinary SharesElectromedical Equipment
TRNSTranscat IncInstruments for Measuring
FEIMFrequency Electronics, Inc.Instruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$8.80

High$32.71